Why is The Chemours (CC) stock down today?

Chemours fell 18.68% to $14.58 on August 5, 2026, after reporting second-quarter results that missed both earnings and revenue expectations. The company posted Q2 EPS of $0.05 against an estimated loss of $0.04 — so it beat on the bottom line — but revenue came in below analyst forecasts, and management simultaneously widened the downside of its full-year 2026 sales guidance, cutting the low end from $5.982 billion to $5.866 billion against a consensus estimate of $6.044 billion. That combination of a revenue miss and a lowered outlook was the dominant driver of the selloff.

The guidance cut extended into Q3 as well: Chemours guided Q3 sales to a range of $1.511 billion–$1.591 billion, which fell short of the $1.601 billion analyst estimate. The WSJ summarized the situation bluntly — 'Data-Center Cooling Couldn't Save the Quarter' — suggesting that growth in demand for Chemours' thermal management products tied to data centers was not enough to offset weakness elsewhere in the portfolio. The Q2 earnings call also highlighted a strategic portfolio review and discussion of the company's Titanium & Sensory Solutions (TSS) segment.

The broader market provided little cushion: the S&P 500 was down 0.17% and the Nasdaq-100 (tracked by QQQ) was off 0.90% on the day, so the macro backdrop was mildly negative but far from the scale of Chemours' decline. The stock's move was overwhelmingly company-specific.

As of the close of trading on August 5, Chemours carries a market capitalization of approximately $2.19 billion. The company also declared a Q3 dividend during the earnings announcement. The stock traded in a range of $14.58 to $16.05 on the day, finishing at the bottom of that range.